- Home
- OSUR vs GCO Comparison
OSUR vs GCO Comparison
Compare OSUR & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- GCO
- Stock Information
- Founded
- OSUR 2000
- GCO 1924
- Country
- OSUR United States
- GCO United States
- Employees
- OSUR N/A
- GCO N/A
- Industry
- OSUR Medical/Dental Instruments
- GCO Clothing/Shoe/Accessory Stores
- Sector
- OSUR Health Care
- GCO Consumer Discretionary
- Exchange
- OSUR Nasdaq
- GCO Nasdaq
- Market Cap
- OSUR 223.0M
- GCO 238.4M
- IPO Year
- OSUR 1986
- GCO N/A
- Fundamental
- Price
- OSUR $2.88
- GCO $21.73
- Analyst Decision
- OSUR Hold
- GCO Hold
- Analyst Count
- OSUR 1
- GCO 2
- Target Price
- OSUR $3.00
- GCO $23.50
- AVG Volume (30 Days)
- OSUR 749.5K
- GCO 206.0K
- Earning Date
- OSUR 05-07-2025
- GCO 06-04-2025
- Dividend Yield
- OSUR N/A
- GCO N/A
- EPS Growth
- OSUR N/A
- GCO N/A
- EPS
- OSUR N/A
- GCO N/A
- Revenue
- OSUR $161,626,000.00
- GCO $2,325,062,000.00
- Revenue This Year
- OSUR N/A
- GCO $1.67
- Revenue Next Year
- OSUR $6.87
- GCO $1.61
- P/E Ratio
- OSUR N/A
- GCO N/A
- Revenue Growth
- OSUR N/A
- GCO 0.02
- 52 Week Low
- OSUR $2.36
- GCO $16.19
- 52 Week High
- OSUR $4.98
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- OSUR 54.19
- GCO 49.81
- Support Level
- OSUR $2.71
- GCO $20.57
- Resistance Level
- OSUR $2.82
- GCO $22.00
- Average True Range (ATR)
- OSUR 0.17
- GCO 0.99
- MACD
- OSUR 0.05
- GCO -0.10
- Stochastic Oscillator
- OSUR 80.62
- GCO 26.30
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.